Diabetes Mellitus, Type 2

• University of Arizona — Tucson, Arizona, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Mobile, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Pell City, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Phoenix, Arizona, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Tucson, Arizona, United States

• Seoul National University Bundang Hospital — Seongnam-si, Gyeonggi-do, South Korea

• Hugh Sinclair Unit, University of Reading — Reading, Berkshire, United Kingdom

• USC — Los Angeles, California, United States

• Multiple Locations, Japan

• Novo Nordisk Investigational Site — Aarhus, Denmark
• Novo Nordisk Investigational Site — München, Germany
• Novo Nordisk Investigational Site — Padova, Italy
• Novo Nordisk Investigational Site — Utrecht, Netherlands

• University of Western Ontario — London, Ontario, Canada
• St. Joseph's Family Medical and Dental Centre — London, Ontario, Canada

• Liverpool John Moores University — Liverpool, Merseyside, United Kingdom

Not specified